Vaccination Critics

modRNA ‘Vaccinations’ Against SARS-CoV-2 Alter the Sensitivity of the Immune System:

by

Inflammatory Response Increases – This Could Explain the Number of Side Effects and Secondary Diseases

A new study recently made the rounds in the press: It has now been proven that the SARS-CoV-2 mRNA ‘vaccination’ is good for the immune system. This is because it trains the immune system in the long term and enables it to respond much more quickly to all kinds of stimuli. Above all, it creates a lasting memory of this initial inflammatory response, which is very promising. I would like to take a closer look at this study from the working group of Prof. Jan Rybniker from Cologne [1] and combine this analysis in a second blog post with a workshop report of my evaluation of the side effect database of the Paul Ehrlich Institute on these very ‘vaccines.’ First, let’s look at the study.

Read more

People With Covid-19 ‘Vaccination’ Are Sicker

by

Our new representative survey has been published, and other data prove this.

Our new representative survey in Germany has recently been published [1]. It shows that people who have had at least one Covid-19 ‘vaccination’ are sicker, have Covid-19 infections and muscle and joint problems more often than people who have not had a ‘vaccination’. The news is piling up and showing that these interventions are dangerous. The high water mark, above which a safety signal should have been triggered, was crossed long ago. Compared to other vaccinations or interventions that have been withdrawn from the market, this ‘vaccination’ is associated with at least five times as many deaths [2].

Our new representative survey on adverse reactions to vaccination

Our survey was recently published by ‘Medical Research Archives’, the official organ of the European Society of Medicine, of which I am a member. You can download the PDF directly here. As we have done before [3], we used a professional panel provided by the company Debaro GmbH. Approximately 20,000 people participate in such a panel, and whenever a new survey is conducted, they are contacted and the company then collects as many responses as needed to reach a number that can be assumed to be representative based on sampling characteristics such as age, gender and socio-economic status.

Read more

The Modified RNA Vaccination Platform is Becoming the Norm for Vaccinations, It Seems…

by

…and this is what needs to be avoided: the approval of Moderna’s mResvia (mRNA1345) proves it

On 15 August 2024, the US Advisory Committee on Immunization Practices (ACIP), issued a recommendation that older people aged 60 and over should receive a dose of a respiratory syncytial virus vaccine. The Centers for Disease Control, the public health authority, recently published this in its weekly report [1]. A new product appears prominently there, the modified RNA prevention, mRNA1345 from Moderna, which is sold under the trade name mResvia.

This is a new gene therapy prevention therapy, referred to as a ‘vaccine’. The corresponding approval study was published in 2023 [2]. I took a closer look at this because I was once again interested in the risk-benefit ratio.

It is important to know that respiratory syncytial viruses (RSVs) are common viruses that are found in every kindergarten, every school class, and every nursing home. Anyone who comes into contact with them and is susceptible will get a cold, cough, hoarseness, maybe even a fever: especially in older people, an infection can develop that takes a more severe course. Probably similar to a corona infection. Basically harmless. Exceptions not ruled out.

Read more